[go: up one dir, main page]

ES2166353T3 - Tratamiento de la hipertension ocular con beta-bloqueantes y derivados del acido prostanoico. - Google Patents

Tratamiento de la hipertension ocular con beta-bloqueantes y derivados del acido prostanoico.

Info

Publication number
ES2166353T3
ES2166353T3 ES92307700T ES92307700T ES2166353T3 ES 2166353 T3 ES2166353 T3 ES 2166353T3 ES 92307700 T ES92307700 T ES 92307700T ES 92307700 T ES92307700 T ES 92307700T ES 2166353 T3 ES2166353 T3 ES 2166353T3
Authority
ES
Spain
Prior art keywords
beta
treatment
ocular hypertension
blockers
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92307700T
Other languages
English (en)
Inventor
Ryuji Ueno
Sachiko Kuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ES2166353T3 publication Critical patent/ES2166353T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTA UN AGENTE PARA EL TRATAMIENTO DE LA HIPERTENSION OCULAR QUE COMPRENDE A) UN BLOQUEADOR BETA-ADRENERGICO QUE SE ADMINISTRA EN LA FASE DE MEJORA DE LA PRODUCCION DEL HUMOR ACUOSO Y B) UN COMPUESTO DE ACIDO PROSTANOICO QUE SE ADMINISTRA EN LA FASE DE SUSPENSION DE LA PRODUCCION DEL HUMOR ACUOSO, LOS COMPONENTES A) Y B) ESTAN CONTENIDOS EN FORMAS DE DOSIFICACION SEPARADAS.
ES92307700T 1992-03-19 1992-08-24 Tratamiento de la hipertension ocular con beta-bloqueantes y derivados del acido prostanoico. Expired - Lifetime ES2166353T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6331692 1992-03-19

Publications (1)

Publication Number Publication Date
ES2166353T3 true ES2166353T3 (es) 2002-04-16

Family

ID=13225754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92307700T Expired - Lifetime ES2166353T3 (es) 1992-03-19 1992-08-24 Tratamiento de la hipertension ocular con beta-bloqueantes y derivados del acido prostanoico.

Country Status (9)

Country Link
US (1) US5432174A (es)
EP (1) EP0561073B1 (es)
JP (1) JPH0640919A (es)
AT (1) ATE207360T1 (es)
DE (1) DE69232150T2 (es)
DK (1) DK0561073T3 (es)
ES (1) ES2166353T3 (es)
GR (1) GR3037008T3 (es)
PT (1) PT561073E (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US5721273A (en) * 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5627209A (en) * 1993-12-15 1997-05-06 Alcon Laboratories, Inc. Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
WO1998021180A1 (en) 1995-06-07 1998-05-22 Alcon Laboratories, Inc. Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
JP4248022B2 (ja) 1996-11-12 2009-04-02 アルコン ラボラトリーズ，インコーポレイテッド 眼圧降下剤としての１５―フルオロプロスタグランジン
US6680339B2 (en) 1996-11-12 2004-01-20 Alcon Manufacturing, Ltd. 15-fluoro prostaglandins as ocular hypotensives
US6353014B1 (en) 1996-11-12 2002-03-05 Alcon Laboratories, Inc. 15-ketal postaglandins for the treatment of glaucoma or ocular hypertension
JP2001504122A (ja) 1996-11-12 2001-03-27 アルコン ラボラトリーズ，インコーポレイテッド 眼圧降下剤としてのプロスタグランジン類のｃｉｓ―δ▲上４▼アナログ
DK0979652T3 (da) * 1997-10-13 2006-09-11 R Tech Ueno Ltd Helbredende præparat til intraokulær hypertension eller glaukom
US6232344B1 (en) 1997-12-22 2001-05-15 Alcon Laboratories, Inc. 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6376541B1 (en) 1998-11-06 2002-04-23 Alcon Manufacturing, Ltd. Upregulation of endogenous prostaglandins to lower intraocular pressure
US6096783A (en) * 1998-12-15 2000-08-01 Alcon Laboratories, Inc. Cyclobutane prostaglandin analogues as ocular hypotensive agents
US6211226B1 (en) 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6160013A (en) * 1998-12-17 2000-12-12 Alcon Laboratories, Inc. 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension
WO2000038667A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of glaucoma
WO2000038663A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
US6576663B2 (en) 1999-12-22 2003-06-10 Alcon, Inc. 6-Keto prostaglandin F1α and analogs for treating dry eye
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
EP1390035A1 (en) * 2001-05-14 2004-02-25 Sucampo AG Method for treating ocular hypertension and glaucoma
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
EP1859802A3 (en) * 2003-09-05 2007-12-19 Novartis AG Compositions comprising benzo(G)quinoline derivates and prostaglandin derivates
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
DE3871596T3 (de) * 1987-04-03 2000-09-07 Pharmacia & Upjohn Ab, Stockholm Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes.
ES2084771T3 (es) * 1990-05-22 1996-05-16 R Tech Ueno Ltd Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.

Also Published As

Publication number Publication date
GR3037008T3 (en) 2002-01-31
ATE207360T1 (de) 2001-11-15
DK0561073T3 (da) 2001-11-12
JPH0640919A (ja) 1994-02-15
DE69232150T2 (de) 2002-03-07
PT561073E (pt) 2002-04-29
EP0561073A1 (en) 1993-09-22
US5432174A (en) 1995-07-11
DE69232150D1 (de) 2001-11-29
EP0561073B1 (en) 2001-10-24

Similar Documents

Publication Publication Date Title
ES2166353T3 (es) Tratamiento de la hipertension ocular con beta-bloqueantes y derivados del acido prostanoico.
EP0105635A3 (en) Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therepeutic agents
FI902258A0 (fi) Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi
EP1514548A3 (en) Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension
ES2105333T3 (es) Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
MXPA03010146A (es) Composiciones de lipidos hipotensivos (derivados de prostaglandina) y timolol, y metodos para usar las mismas.
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
EP0045617A3 (en) Pharmaceutical composition
IE56177B1 (en) Celiprolol for the treatment of glaucoma
IE810785L (en) Anti-inflammatory ophthalmic composition
EA199900659A1 (ru) Водная суспензия для введения в нос
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
ES2091941T3 (es) Potenciador del efecto antineoplasico y agente antineoplasico.
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
MY103498A (en) Dl-5-[(2-benzyl-3, 4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2, 4-dione as an anti-atherosclerosis agent
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
RU93019277A (ru) Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
KR880004810A (ko) 소화성 궤양 치료제
AR246958A1 (es) Procedimiento para preparar 1-hidroximetilpirazol.
RU95106983A (ru) Офтальмологический состав, способ его получения и средство для офтальмологического состава
JPS6426518A (en) Remedy for hyperophthalmotony
AU5992786A (en) Increasing aqueous humor outflow
HU9301364D0 (en) Homo-prostaglandines applicables for treatment of hypertension in eyes
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 561073

Country of ref document: ES